Objectives: The aims of the present study was to examine the associations between the severity of pain and anxiety in a community population reporting joint pain, and to investigate the management of joint pain in the presence of comorbid anxiety.
| BACKGROUND
Joint pain due to osteoarthritis (OA) is a common presenting complaint in primary care. In North Staffordshire, UK, one in seven primary care consultations is estimated to be for a musculoskeletal problem (Jordan et al., 2010) and 10% of the population aged ≥45 years is recorded annually as having a consultation about OA or joint pain . The National Institute for Health and Care Excellence (NICE) guidance states that OA can be diagnosed clinically, without further investigations, in people over 45 years of age who have activity-related joint pain, no more than 30 min of morning stiffness and no atypical features suggesting an alternative diagnosis (National Institute for Health & Care Excellence, 2014) . NICE recommends that patients with OA should have an agreed self-management strategy, with core management including access to appropriate information, physical activity and exercise, and support for weight loss if needed (body mass index
[BMI] ≥25 kg/m 2 ) (National Institute for Health & Care Excellence, 2014) . However, pharmacological treatments that are recommended as an adjunct to core treatments often precede or replace these in the management of joint pain (Jinks et al., 2011; Porcheret et al., 2007) .
Exercise as a treatment for OA is well known (Fransen et al., 2015) and it has also been found to be effective in anxiety disorders, albeit less so than antidepressants (Jayakody, Gunadasa, & Hosker, 2014) .
Chronic pain, such as joint pain, is often associated with comorbid anxiety disorders (Axford et al., 2010; McWilliams, Cox, & Enns, 2003; McWilliams, Goodwin, & Cox, 2004; Scott et al., 2007) . Anxiety disorders are associated with an increased frequency of consultation in primary care (Bélanger, Ladouceur, & Morin, 2005) , but people often present with pain and seldom with psychological symptoms (GarciaCampayo, Caballero, Perez, & Lopez, 2012; Wittchen et al., 2002) . Recognition of anxiety disorders in primary care has been identified to be suboptimal (Wittchen et al., 2002) , and the receipt of a physical diagnosis reduces the likelihood of being diagnosed with anxiety (Ballenger et al., 2001 ). Many patients suffer clinically significant symptoms without meeting the diagnostic criteria for an anxiety disorder (Beesdo et al., 2009; Haller, Cramer, Lauche, Gass, & Dobos, 2014) , and general practitioners (GPs) may be more confident in recognizing anxiety symptoms than in making specific anxiety diagnoses (Walters, Rait, Griffin, Buszewicz, & Nazareth, 2012) . Anxiety can be diagnosed formally by a structured clinical assessment, such as the Composite International Diagnostic Interview (World Health Organization, 1990 ), but screening tools have also been used in research to identify what may be termed "clinical anxiety". The Generalized Anxiety Disorder seven-item (GAD-7) scale quantifies anxiety symptoms (Spitzer, Kroenke, Williams, & Lowe, 2006) and can be used to screen for generalized anxiety disorder, panic disorder, social anxiety disorder and post-traumatic stress disorder in primary care (Kroenke, Spitzer, Williams, Monahan, & Lowe, 2007) and the general population (Lowe et al., 2008) . Although it cannot be used to assign specific anxiety disorder diagnoses, a threshold score of 10 or more may be used to classify people as having clinical anxiety (Bair, Wu, Damush, Sutherland, & Kroenke, 2008 ) with a sensitivity of 89% and specificity of 82% for generalized anxiety disorder (Kroenke et al., 2007) . It is quick to administer (Williams, 2014) and has previously been used to determine the presence of anxiety in people with joint pain (Bair et al., 2008) .
There is evidence that anxiety and depression comorbidity is associated with worse pain among primary care patients with chronic musculoskeletal pain (Bair et al., 2008; de Heer et al., 2014) . A metaanalysis of the prevalence of depression and anxiety in people with OA suggested that over 20% of OA patients have anxiety, with a relative risk estimated at 1.35 among people with OA compared with those without, although this did not achieve statistical significance (Stubbs, Hurley, & Smith, 2015) . Factors within clinical OA associated with an increased risk of clinical anxiety require further exploration.
Any associations between different primary care management processes of care and clinical anxiety are also unknown. The objectives of the present analysis were: (i) to examine the relationship between pain (severity, location and number of sites affected) and clinical anxiety in a community population reporting joint pain; and (ii) to investigate the management of joint pain (self-reported processes of care) in the presence of comorbid clinical anxiety.
| METHODS
The Management of Osteoarthritis in Consultations Study (MOSAICS) was a programme of research to develop a model primary care consultation for OA, and test its feasibility and acceptability in primary care.
A cross-sectional population survey formed a key component of this programme. A full description of the methods, outcome measures and analysis plan has been reported in the protocol (Dziedzic et al., 2014) . In brief, participants were recruited from eight general practices in the North West Midlands and Cheshire. Between May 2011
and February 2012, patients registered with the participating practices who were aged ≥45 years, did not have a diagnosis of inflammatory arthritis or serious comorbidity, and did not have an inability to attend the surgery or consent to the research were sent an invitation to complete the MOSAICS population survey.
Respondents were asked to report the intensity of pain in their hands, hips, knees and feet during the previous month on a numerical rating scale from 0 to 10. As supported by the patient and public involvement group for quantifying multi-site pain, a "worst pain" score was calculated as the greatest value given for any joint (Finney, Dziedzic, Lewis, & Healey, 2015) . Pain scores were classified as none (0), mild (1-3), moderate (4-6) or severe (7-10) pain, as described in previous studies of musculoskeletal pain (Salaffi, Ciapetti, & Carotti, 2012) and in primary care (Krebs, Carey, & Weinberger, 2007) .
Anxiety symptoms were assessed using the GAD-7 scale. This score is calculated from the frequency of seven anxiety symptoms in the previous 2 weeks, and gives a result from 0 to 21, where higher scores indicate worse anxiety (Spitzer et al., 2006) . When one item was missing, we used the mean of the other six responses for the missing value; if more than one item was missing, no total GAD-7 score was calculated (Kroenke et al., 2007) .
The management of joint pain was assessed using the Knee Pain Screening Tool (KNEST) (Jinks, Jordan, Ong, & Croft, 2004) , expanded for use in the hands, hips, knees and feet, and included treatments listed in national guidelines for OA management (Box 1) (Conaghan, Dickson, Grant, & Guideline Development, 2008) . For each treatment, respondents were asked to state whether they had used it in the previous 12 months, and whether it had been obtained from the National Health Service (NHS), another source or both. 
| Analysis
The analysis included all respondents who completed sufficient items for a total GAD-7 score to be calculated, and reported a worst pain score of at least 1, indicating that they had at least some joint pain.
Respondents were dichotomized to the presence of clinical anxiety at or above a GAD-7 threshold score of 10 (Bair et al., 2008) .
The associations of anxiety with joint pain intensity, with location of pain and with number of pain sites were determined first unadjusted, and then adjusted for potential confounding variables (age, gender, marital status, living alone, employment status, IMD, BMI and registered general practice) using binary logistic regression and presented as odds ratios (ORs) with 95% confidence intervals (CIs). The association of self-reported use of each treatment for joint pain with clinical anxiety was also determined using binary logistic regression analysis, adjusting for worst pain intensity, number of joints with a pain score of at least one, age, gender, marital status, living alone, employment status, IMD, BMI and general practice. Dieting to lose weight was analysed separately for all respondents and for those with a BMI of 25 kg/m 2 or greater. Analysis was repeated, stratified by source of treatment (NHS versus non-NHS).
Individual patient consent was obtained for every respondent to this survey. This research was approved by the North West 1 Research Ethics Committee, Cheshire, UK (reference number 10/H1017/76).
| RESULTS
The survey was mailed to 28,443 people, and 15,083 were returned completed (response rate 53.0%). A total of 11,534 (76.5%) respondents reported pain in at least one joint in the previous month. Of these, 11,222 (97.3%) completed sufficient items for a GAD-7 to be calculated.
These 11,222 formed the study population for the analysis (Table 1 ).
The knee was the most common site of reported joint pain (7, Table 2 ).
Compared with the knee, clinical anxiety was more frequent in people with pain in the foot (adjusted OR 1.35, 95% CI 1.14 to 1.61) or in multiple sites (adjusted OR 1.39, 95% CI 1.19 to 1.63).
A total of 4,449 (39.6%) respondents reported visiting their GP with a joint problem in the year before completing the questionnaire (Table 3 ). Of these, 1,006 (22.6%) reported clinical anxiety. Respondents with anxiety were significantly more likely to report using each consultation option listed in the KNEST instrument, except physiotherapy, podiatry and osteopathy (Table 3 ). There was no statistically significant difference between respondents with and without clinical anxiety in reported use of NHS or private physiotherapy services.
The most frequently reported treatments were paracetamol and topical anti-inflammatory drugs. Participants with clinical anxiety were significantly more likely to report using walking aids or strong painkillers such as opioids, and less likely to do general fitness exercises or muscle-strengthening exercises ( 
| DISCUSSION
From a community sample of 11,222 people reporting joint pain, we showed a significant association between joint pain intensity and anxiety severity, which is consistent with previous literature (Bair et al., 2008; de Heer et al., 2014) . At all levels of pain reported, Includes "Not working due to ill health", "Unemployed/seeking work", "Housewife" and "Other2. Higher levels of anxiety are also associated with lower income levels (Lejtzén, Sundquist, Sundquist, & Li, 2014) . We might expect people with a lower income to be less able to pay for private provision, and they are more likely to receive NHS-prescribed medications free of charge (NHS Choices, 2013), which might influence their help-seeking.
There is some evidence that a collaborative care approach including brief, low-intensity psychological therapy in primary care
can reduce the severity of depression and anxiety, as well as improve self-management of chronic conditions (diabetes and cardiovascular disease) (Coventry et al., 2015) . With suitable case-finding for anxiety symptoms in people with joint pain, provision of, or referral for, such intervention could usefully be considered, such as that being tested in the ENHANCE study .
The present study was pragmatic, including a large number of people living in the community with symptoms of joint pain and anxiety. It was the first study to investigate comprehensive management options recommended by national guidance for OA pain in the presence of anxiety. Our questionnaire data were not intended to assign specific OA or anxiety disorder diagnoses. Instead, we focused on the symptoms with which patients are likely to present to their GPs, and grouped people into clinical OA or anxiety on the basis of reported symptoms. The majority of this survey population would be expected to meet the NICE criteria for a clinical diagnosis of OA.
The survey was not designed to determine the odds of clinical anxiety in people with joint pain relative to the population generally.
The design of a cross-sectional paper-based survey allowed a large number of people from a primary care population to participate.
The response rate of 53% was typical for a population-based postal survey (Hill, Roberts, Ewings, & Gunnell, 1997) , although lower than in previous surveys of patients registered with GPs in this area (Marshall et al., 2013) . When response rates are low, respondents may not necessarily be representative of the wider community (Hill et al., 1997) , although a systematic review found no effect of response rate on the recorded prevalence of anxiety disorders (Baxter, Scott, Vos, & Whiteford, 2013) . As a result of the sampling frame used, the response rate and the clinical anxiety prevalence being comparable with previous evidence (Stubbs et al., 2016) , we consider the results of the present survey to be generalizable to UK primary care populations presenting with joint pain.
The instruments used in the survey considered different timescales: GAD-7 questions consider the previous 2 weeks, the numerical pain scales covered the previous month, and the KNEST included treatments over the previous 12 months. Clinical anxiety symptoms tend to be chronic (Spitzer et al., 2006) , but joint pain is reported as being variable over days and weeks (Gooberman- Hill et al., 2007) .
The use of a single cross-sectional questionnaire precluded the drawing of conclusions regarding causal or temporal (direction of association) relationships between joint pain and anxiety symptoms.
We were also unable to determine the effects of treatments taken previously. For example, respondents reporting high levels of analgesia use and low levels of pain equally might reflect successful management of pain or inappropriately high levels of analgesia, and respondents using adjunctive treatments for their joint pain may have tried core treatments previously and found them unsuccessful. Information provision was reported as poor, but for those with symptoms of several years' duration, the information may have been provided more than 1 year earlier. There was also a risk of recall bias. For example, treatments that were not successful might have been recalled less than more successful interventions. In addition, patients expecting a pharmacological intervention might have been more likely to recall prescriptions they received than the provision of information.
We performed multiple comparisons in the present analysis.
Although a number of significant results at the p < 0.05 level would be expected by chance, the gradient of odds of clinical anxiety seen with increasing pain severity and number of pain sites means that these observations were likely to be valid and in keeping with previous evidence (de Heer et al., 2014) . We controlled for multiple potential confounding factors, although residual confounding remained a risk.
However, we consider that in the primary care setting, the mechanism linking anxiety with joint pain may be less important than recognizing that a relationship exists and seeking to improve recognition of anxiety symptoms in OA patients. we consider that it would be a proportionate and justifiable approach for this population. The Improving Access to Psychological Therapies services use a GAD-7 threshold score of 8 to define cases (Clark et al., 2009) , so referral to these services could be offered to patients meeting the clinical anxiety threshold used in our study.
| CONCLUSIONS
NICE guidance on the management of OA emphasizes the importance of a self-management strategy and use of core treatments (National Institute for Health & Care Excellence, 2014). The majority of respondents, with or without anxiety, did not report adherence to these recommendations within the previous year. The broader MOSAICS programme is investigating the feasibility of improving access to core treatments (Dziedzic et al., 2014) . As discussed, self-management and use of core treatments are particularly beneficial for patients with comorbid anxiety, yet we have shown that they are least likely to be following this approach. We therefore propose that additional efforts are made by clinicians to encourage and facilitate patients with comorbid anxiety to self-manage their pain with core non-pharmacological treatments, and that particular attention is paid to the application of guidelines in managing joint pain for those with comorbid anxiety.
